A practical reference on PPARδ agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-04-29. Anything still debated is marked as such rather than presented as settled.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516, GW-501516, GW 501516, endurobol | Names vary in research and anti-doping documents. |
| Chemical class | Synthetic PPARδ agonist | Small-molecule nuclear receptor ligand. |
| CAS Registry Number | 317318-70-0 | Identifier commonly associated with GW501516. |
| Appearance | White to off-white powder | Typical for purified research material. |
| Solubility | Low in water; soluble in DMSO and ethanol | Organic solvents are common for laboratory stock solutions. |
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
=== Generic names === Buserelin is the generic name of the drug and its INNTooltip International Nonproprietary Name and BANTooltip British Approved Name, while buserelin acetate is its USANTooltip United States Adopted Name, BANMTooltip British Approved Name, and JANTooltip Japanese Accepted Name, buséréline is its DCFTooltip Dénomination Commune Française, and buserelina is its DCITTooltip Denominazione Comune Italiana. While under development by Hoechst AG, buserelin was also known as HOE-766.
{\displaystyle \langle \Psi _{nlm_{l}m_{s}}|\mu |\Psi _{n'l'm_{l}'m_{s}'}\rangle } For example in the E1 transition, unless Δ l = ± 1, Δ ml = 0 or ± 1, Δ ms = 0, and Δ n = any integer, the equation above will yield a value equal to zero and the transition would be known as a “forbidden transition”. For example, this would occur for certain cases like when Δ l = 2. In this case, the transition would not be allowed and therefore would be much weaker than an allowed transition. These specific values for the changes in quantum numbers are known as the selection rules for the allowed transitions and are shown for common transitions in the table below: Cold vapour atomic fluorescence spectroscopy Atomic spectral line Prospects in Analytical Atomic Spectrometry – tendencies in five main branches of atomic spectrometry (absorption, emission, mass, fluorescence and ionization spectrometry) Learning by Simulations – various atomic absorption and emission spectra Atomic Spectroscopy: A Compendium of Basic Ideas, Notation, Data, and Formulas
The move resulted in a backlash from the gaming community, and Firewatch was "review-bombed" on Steam. Ars Technica noted that the company previously stated on their website that they gave open permission to stream and monetize videos made while playing the game. On April 21, 2018, Campo Santo announced that they had been acquired by Valve and would subsequently move to Valve's Bellevue, Washington headquarters and continuing In the Valley of Gods as a Valve game. According to Vanaman and Rodkin, after the success of Firewatch, they started internal discussions of where they wanted to take their company. These discussions continued informally with third parties, including Valve's Robin Walker, Erik Johnson and Scott Lynch. These Valve employees suggested that Campo Santo could retain its own direction while being wholly within Valve, yet still draw from Valve's knowledge and expertise. Vanaman and Rodkin discussed this more formally with Valve, ultimately leading to the acquisition. Development on In The Valley of Gods was put on hold in July 2019, partially due to head writer Sean Vanaman moving to the writing team for Half-Life: Alyx, which had not been announced to the public at the time. In November 2019, it was noted by journalists that Claire Hummel, Jane Ng, and Rodkin had removed In the Valley of Gods from their Twitter profile descriptions. The game also disappeared from Campo Santo's website and the original announcement trailer was made private on YouTube, though the website and its Steam profile page were still available.
Sources: en.wikipedia.org
== Metabolism == Safrole can undergo many forms of metabolism. The two major routes are the oxidation of the allyl side chain and the oxidation of the methylenedioxy group. The oxidation of the allyl side chain is mediated by a cytochrome P450 complex, which will transform safrole into 1′-hydroxysafrole. The newly formed 1′-hydroxysafrole will undergo a phase II drug metabolism reaction with a sulfotransferase enzyme to create 1′-sulfoxysafrole, which can cause DNA adducts. A different oxidation pathway of the allyl side chain can form safrole epoxide. So far, this has only been found in rats and guinea pigs. The formed epoxide is a small metabolite due to the slow formation and further metabolism of the compound. An epoxide hydratase enzyme will act on the epoxide to form dihydrodiol, which can be secreted in urine. The metabolism of safrole through the oxidation of the methylenedioxy proceeds via the cleavage of the methylenedioxy group. This results in two major metabolites: allylcatechol and its isomer, propenylcatechol. Eugenol is a minor metabolite of safrole in humans, mice, and rats. The intact allyl side chain of allylcatechol may then be oxidized to yield 2′,3′-epoxypropylcatechol. This can serve as a substrate for an epoxide hydratase enzyme, and will hydrate the 2′,3′-epoxypropylcatechol to 2′,3′-dihydroxypropylcatechol. This new compound can be oxidized to form propionic acid (PPA), which is a substance that is related to an increase in oxidative stress and glutathione S-transferase activity.
The draw started with Pot 1 and ended with Pot 4, with each team selected and then allocated into the first available group alphabetically. For the purpose of the match schedule, the Pot 1 teams were automatically drawn into position 1 of each group. For the remaining pots, FIFA established a predetermined pattern to define the position of teams based on their pot and the group they were drawn into.
Solvents can have a powerful effect on solubility, stability, and reaction rate. A change in solvent can also allow a chemist to influence the thermodynamic or kinetic control of the reaction. Reactions proceed at different rates in different solvents due to the change in charge distribution during a chemical transformation. Solvent effects may operate on the ground state and/or transition state structures. An example of the effect of solvent on organic reactions is seen in the comparison of SN1 and SN2 reactions. Solvent can also have a significant effect on the thermodynamic equilibrium of a system, for instance as in the case of keto-enol tautomerizations. In non-polar aprotic solvents, the enol form is strongly favored due to the formation of an intramolecular hydrogen-bond, while in polar aprotic solvents, such as methylene chloride, the enol form is less favored due to the interaction between the polar solvent and the polar diketone. In protic solvents, the equilibrium lies towards the keto form as the intramolecular hydrogen bond competes with hydrogen bonds originating from the solvent.
Sources: en.wikipedia.org
== Description == The African Renaissance is a philosophical and political movement to end the violence, elitism, corruption, and poverty believed to plague the African continent, and to replace them with a more just and equitable order. For Noel Moukala, however, the African Renaissance cannot exist without first achieving African Unity. Okumu compiled a list of perceived African traits that he believes are worthy of preservation and continuation. These include aspects of interpersonal relations, such as "social inclusion, hospitality, and generous sharing," as well as attentive and perceptive listening. He additionally argues that social acceptance is not based on wealth, but on the basis of relationships to others.
=== Constitutional framework and term length === The Constitution of the Bolivarian Republic of Venezuela, adopted in 1999, sets the presidential term at six years. Article 230 establishes the length of the term, while a 2009 constitutional amendment removed term limits for the presidency and other elected offices, allowing indefinite re-election. Article 231 provides that the president-elect must take office on 10 January of the first year of the term by swearing an oath before the National Assembly, or before the Supreme Tribunal of Justice when circumstances prevent inauguration before the legislature. Article 233 regulates the "absolute absence" of the president (due to death, resignation, removal by the TSJ, permanent incapacity, abandonment of office or recall by referendum). If such an absence occurs in the first four years of the term, a new presidential election must be called within 30 days and the executive vice-president assumes the presidency on an interim basis; in the last two years, the executive vice-president completes the term. If the president is only deemed "temporarily unavailable", the executive vice-president may temporarily assume the presidency for 90 days, and—subject to the approval of the National Assembly—this interim period may be extended by another 90 days, for a total of six months.
Early remediation strategies focused on the restoration of aquifer quality via the construction of wells to extract and treat groundwater (the pump-and-treat strategy), but it soon became clear that the volume of water to be extracted and treated was unreasonably large and unfeasible. Additionally, the construction of wells can be invasive to the subsurface environment and can cause deeper infiltration of NAPLs, which is counter-productive. While some experts have proposed that the complete removal of NAPLs from the subsurface environment is impossible, others view the challenge as an opportunity to expand and innovate remediation technologies. As a result, a variety of innovations to both detect and mitigate NAPLs have been developed from the 1980s to the mid-2000s providing alternatives to the pump-and-treat strategy.
Ion Torrent Systems Inc. (now owned by Life Technologies) developed a system based on using standard sequencing chemistry, but with a novel, semiconductor-based detection system. This method of sequencing is based on the detection of hydrogen ions that are released during the polymerisation of DNA, as opposed to the optical methods used in other sequencing systems. A microwell containing a template DNA strand to be sequenced is flooded with a single type of nucleotide. If the introduced nucleotide is complementary to the leading template nucleotide it is incorporated into the growing complementary strand. This causes the release of a hydrogen ion that triggers a hypersensitive ion sensor, which indicates that a reaction has occurred. If homopolymer repeats are present in the template sequence, multiple nucleotides will be incorporated in a single cycle. This leads to a corresponding number of released hydrogens and a proportionally higher electronic signal.
Sources: en.wikipedia.org
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.
No. Cardarine is not a steroid hormone; it targets the nuclear receptor PPARδ. Its classification in anti-doping rules differs from anabolic steroids, though it remains prohibited in sport.
Early rodent studies reported tumor formation at multiple sites, which raised safety concerns. Sponsors stopped clinical development, and no approved human product exists.
Anti-doping and clinical laboratories commonly use liquid chromatography-tandem mass spectrometry. The method can identify GW501516 and its metabolites in urine or blood. Detection depends on sample timing and the amount present.